Oxford Immune Algorithmics develops Algocyte®, a precision diagnostics platform that utilizes Artificial General Intelligence to create digital blood-based twins for remote health monitoring. This technology addresses the challenges of chronic disease management and early detection by providing personalized risk assessments and predictive insights based on individual health data.
Funding
$18.7M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Managing chronic diseases and enabling early detection are difficult due to the limitations of traditional diagnostic methods, which often require specialized equipment and are not easily accessible for remote monitoring. This can lead to delays in diagnosis and treatment, hindering effective healthcare management.
Solution
Oxford Immune Algorithmics (OIA) offers Algocyte®, a precision diagnostics platform that uses Artificial General Intelligence (AGI) to create digital blood-based twins for remote health monitoring. Algocyte® analyzes individual health data to provide personalized risk assessments and predictive insights, enabling early detection and proactive management of chronic diseases. The platform integrates biochemistry, biomedical imaging, mechatronics, and nanotechnology with AI to learn and build a detailed digital representation of an individual's health, tracking deviations and testing hypotheses for differential prediction. This approach facilitates remote digital care, supports clinical pathways, and enables home-driven precision medicine.
Target Audience
The primary target audience includes healthcare providers, life science companies, and governments seeking to implement predictive population health management strategies, as well as individuals requiring remote health monitoring and early disease detection.
Features
- AGI-driven solutions for remote and personal digital endpoints in healthcare pathways.
- End-to-end automated portable lab for at-home health monitoring, capable of detecting conditions from anemia to cancer.
- Ability to ingest multiple data streams from various IoT devices, cross-referencing clinical, biological, and lifestyle data.
- Open platform for commercial and academic solutions, deployable via software and reagent updates based on light, spectral, and immunofluorescence microscopy.
- Automation tools for classification and triaging of users and patients.
- Advanced AI-reasoning and predictive capabilities for remote care and precision healthcare.
- Quantitative risk assessment scores based on personalized norms for professionals to analyze user results and flag concerning trends.
- Individualized learning and monitoring based on a digital twin baseline, allowing forecasting, prediction, and diagnosis.